Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Adagio Medical Holdings, Inc.ADGM · Entity 7926 | Director | June 16, 2026 | August 12, 2026 |
| Lucid Diagnostics Inc.LUCD · Entity 6375 | Director | February 20, 2026 | February 24, 2026 |
| PAVmed Inc.PAVM · Entity 7317 | Director | February 22, 2024 | February 23, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Adagio Medical Holdings, Inc.
Report date June 16, 2026 · Filed August 12, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-qualified stock option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.71 · Expires 2036-06-16 | Direct | 30,000 |
Reported balance
After 2026-06-16 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-16 · Grant · Acquired 30,000 · Balance 30,000 F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026.
Lucid Diagnostics Inc.
Report date February 20, 2026 · Filed February 24, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 405,120 |
Reported balance
After 2026-02-20 transaction · row 1
1 source rowRow 1 · 2026-02-20 · Grant · Acquired 123,000 · Balance 405,120 F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed
PAVmed Inc.
Report date February 22, 2024 · Filed February 23, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common stockSEC Table I · non-derivative | Direct | 65,000 |
Reported balance
After 2024-02-22 transaction · row 1
1 source rowRow 1 · 2024-02-22 · Grant · Acquired 65,000 · Balance 65,000 F1: The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2026 Filed Aug 12, 2026 17:47 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 30,000 | $0.00 Strike: $0.71 | $0.00 |
DisclosureSEC source: 0001665442-26-000002 · form4-08122026_050857.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2036-06-16 F1 · security: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. F1 · derivative.exercise_date: Annual stock option granted under the Issuer's Non-Employee Director Compensation Policy and the Issuer's 2024 Equity Incentive Plan (the "Option"). The Option will vest in equal monthly installments over a one-year period, whereby 1/12th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of 06/16/2026. Read SEC document |
| February 20, 2026 Filed Feb 24, 2026 23:42 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon Stock | 123,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001094891-26-000068 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 405,120 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2029. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 23:00 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 364,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001415889-25-008807 · form4-03212025_110314.xml · derivative · entry 2 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 364,000 Underlying: Common Stock · 364,000 shares Expires 2035-03-20 F2 · security: Stock Option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Special Option"). Special Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Special Option is vested in full as of the grant date. F2 · derivative.exercise_date: Stock Option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Special Option"). Special Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Special Option is vested in full as of the grant date. Read SEC document |
| March 20, 2025 Filed Mar 21, 2025 23:00 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | GrantNon-qualified stock option (right to buy) · Derivative | 90,000 | $0.00 Strike: $0.87 | $0.00 |
DisclosureSEC source: 0001415889-25-008807 · form4-03212025_110314.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,000 Underlying: Common Stock · 90,000 shares Expires 2034-07-31 F1 · security: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024. F1 · derivative.exercise_date: Stock option granted pursuant to Issuer's 2024 Equity Incentive Plan (the "Option"). Option was approved by the Issuer's Compensation Committee on March 20, 2025. The Option will vest over a three-year period, whereby 1/36th of shares underlying the Option shall vest in equal monthly installments at the conclusion of each month of continuous service after the vesting commencement date of July 31, 2024. Read SEC document |
| February 20, 2025 Filed Feb 21, 2025 22:08 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantCommon Stock | 112,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-25-003174 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 282,120 F1 · shares: Represents restricted stock granted to the reporting person under the Issuer's 2018 Equity Plan with a single vesting date of May 20, 2028. Such restricted stock is subject to forfeiture if the requisite service period is not completed Read SEC document |
| July 31, 2024 Filed Aug 2, 2024 12:00 UTC | Adagio Medical Holdings, Inc. ADGM · Entity 7926 | OtherCommon Stock | 36,698 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001140361-24-035440 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,698 F1 · kind: Pursuant to the business combination (the "Business Combination") contemplated by the Business Combination Agreement (the "BCA"), dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., "New Adagio" and following the completion of the Business Combination, the "Issuer"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. ("Adagio") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held by the reporting person prior to the completion of the Business Combination. F1 · price: Pursuant to the business combination (the "Business Combination") contemplated by the Business Combination Agreement (the "BCA"), dated February 13, 2024, as amended, by and among Adagio Medical Holdings, Inc. (formerly known as Aja Holdco Inc., "New Adagio" and following the completion of the Business Combination, the "Issuer"), ARYA Sciences Acquisition Corp IV, Adagio Medical, Inc. ("Adagio") and certain other parties thereto, as described in the Registration Statement on Form S-4 (File No. 333-278811) filed with the U.S. Securities and Exchange Commission and declared effective on July 12, 2024, acquired by the reporting person in exchange for the shares of Adagio common stock held by the reporting person prior to the completion of the Business Combination. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:46 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantEmployee stock option (right to buy) · Derivative | 150,000 | $0.00 Strike: $1.23 | $0.00 |
DisclosureSEC source: 0001062993-24-004284 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 150,000 Underlying: Common stock · 150,000 shares Expires 2034-02-22 F1 · derivative.exercise_date: One third of the option vests on December 31, 2024; the balance vests in eight equal quarterly installments, starting March 31, 2025. Read SEC document |
| February 22, 2024 Filed Feb 23, 2024 21:41 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantCommon stock | 65,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-24-004277 · form4.xml · nonDerivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 F1 · price: The issuer granted 65,000 shares of restricted stock to the reporting person pursuant to its long term incentive equity plan. Read SEC document |
| January 31, 2023 Filed Feb 3, 2023 01:38 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantEmployee stock option (right to buy) · Derivative | 175,000 | $0.00 Strike: $1.31 | $0.00 |
DisclosureSEC source: 0001062993-23-002036 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common stock · 175,000 shares Expires 2033-01-31 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| January 30, 2023 Filed Feb 3, 2023 01:41 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 450,000 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001062993-23-002040 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 450,000 Underlying: Common stock · 450,000 shares Expires 2033-01-30 F1 · derivative.exercise_date: One third of the option vests on March 31, 2023; the balance vests in eight equal quarterly installments, starting June 30, 2023. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:18 UTC | Lucid Diagnostics Inc. LUCD · Entity 6375 | GrantEmployee stock option (right to buy) · Derivative | 59,000 | $0.00 Strike: $3.95 | $0.00 |
DisclosureSEC source: 0001062993-22-005487 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,000 Underlying: Common stock · 59,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| February 18, 2022 Filed Feb 24, 2022 01:19 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee stock option (right to buy) · Derivative | 80,000 | $0.00 Strike: $1.59 | $0.00 |
DisclosureSEC source: 0001062993-22-005488 · form4.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common stock · 80,000 shares Expires 2032-02-18 F1 · derivative.exercise_date: The option vests in 12 quarterly installments, with first installment vesting March 31, 2022. Read SEC document |
| April 01, 2021 Filed Apr 5, 2021 22:31 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $4.44 | $0.00 |
DisclosureSEC source: 0001094891-21-000176 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-04-01 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on September 30, 2021. Read SEC document |
| April 30, 2020 Filed May 4, 2020 21:46 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001094891-20-000070 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2030-04-30 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on June 30, 2020. Read SEC document |
| March 07, 2019 Filed Mar 12, 2019 12:01 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001094891-19-000089 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 200,000 shares Expires 2029-03-07 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2019. Read SEC document |
| February 14, 2018 Filed Feb 16, 2018 21:27 UTC | PAVmed Inc. PAVM · Entity 7317 | GrantEmployee Stock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001094891-18-000052 · edgar.xml · derivative · entry 1 Cox James L · CIK 0001665442 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2028-02-14 F1 · derivative.exercise_date: The option vests in 12 equal quarterly installments commencing on March 31, 2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.